CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE EARNINGS AND LOSS (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Income Statement [Abstract]
Operating revenues (net of contractual allowances)	$ 116,495	$ 120,078	$ 123,269
Less provision for bad debts of Healthcare Facilities Segment	11,065	11,770	10,053
Net Revenues	105,430	108,308	113,216
Costs and expenses:
Cost of goods sold	22,110	22,363	26,073
Salaries, wages and benefits	51,096	52,660	52,115
Provision for bad debts of Specialty Pharmacy Segment and Other	254	597	632
Supplies	8,605	9,095	8,428
Purchased services	7,183	7,480	7,958
Other operating expenses	14,696	15,400	15,661
Rents and leases expense	1,775	1,918	2,191
Impairment of property, plant and equipment	0	789	0
Impairment of goodwill and intangible assets	0	0	931
Depreciation and amortization	3,662	4,048	4,365
Electronic Health Records incentive payments	(3,911)	(4,947)	(7,294)
Operating profit (loss)	(40)	(1,095)	2,156
Other income (expense):
Interest expense	(1,220)	(1,796)	(4,377)
Loss on sale of assets	(43)	0	(20)
Loss from continuing operations before income taxes	(1,303)	(2,891)	(2,241)
Income tax (benefit) expense	88	(1,306)	(565)
Loss from continuing operations	(1,391)	(1,585)	(1,676)
Earnings from discontinued operations, net of income taxes	846	6,073	2,757
Net earnings (loss)	(545)	4,488	1,081
Other comprehensive income (loss)	72	91	(219)
Comprehensive income (loss)	$ (473)	$ 4,579	$ 862
Continuing operations:
Basic	$ (0.15)	$ (0.17)	$ (0.18)
Diluted	$ (0.15)	$ (0.17)	$ (0.18)
Discontinued operations:
Basic	$ 0.09	$ 0.64	$ 0.29
Diluted	$ 0.09	$ 0.64	$ 0.29
Net earnings (loss):
Basic	$ (0.06)	$ 0.48	$ 0.12
Diluted	$ (0.06)	$ 0.48	$ 0.12
Weighted-average common shares outstanding:
Basic	9,443	9,445	9,350
Diluted	9,443	9,445	9,350